Q&A: No­vo Nordisk sus­tain­abil­i­ty leader de­tails US 'C­i­ties,' pro cy­cling and more to dri­ve di­a­betes aware­ness

While the big me­dia buzz around No­vo Nordisk late­ly is around obe­si­ty drugs, the Den­mark-based phar­ma is al­so and still the largest di­a­betes treat­ment com­pa­ny in the world.

To­day, the day af­ter World Di­a­betes Day, we’re fea­tur­ing a con­ver­sa­tion with Ka­trine Di­Bona, No­vo Nordisk’s VP of glob­al pub­lic af­fairs and sus­tain­abil­i­ty.

Di­Bona over­sees No­vo Nordisk sus­tain­abil­i­ty ef­forts across a range of cor­po­rate, en­vi­ron­men­tal and so­cial ini­tia­tives. From pro­grams around net ze­ro car­bon goals and re­cy­cling plas­tic from in­sulin pens to so­cial move­ments that co­or­di­nate com­mu­ni­ty and na­tion­al groups such as Cities Chang­ing Di­a­betes and Chang­ing Di­a­betes in Chil­dren, Di­Bona and her team work across the grow­ing is­sues of di­a­betes — and No­vo’s cor­po­rate re­spon­si­bil­i­ty to ad­dress them.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER